Evidence map›Paper›PMID 20926131›Full record

ArticleBiomaterials2011

The biocompatibility of titanium cardiovascular devices seeded with autologous blood-derived endothelial progenitor cells: EPC-seeded antithrombotic Ti implants.

Hardean E Achneck, Ryan M Jamiolkowski, Alexandra E Jantzen, Justin M Haseltine, Whitney O Lane, Jessica K Huang, Lauren J Galinat, Michael J Serpe, Fu-Hsiung Lin, Madison Li and 10 more

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 81 citations in OpenAlex.

  1. Trial
  2. Review
  3. Integral Algorithms to Evaluate TiOInternational journal of molecular sciences · 2022
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Continuously Grooved Stent Struts for Enhanced Endothelial Cell Seeding.Cardiovascular and interventional radiology · 2017
    Article
  10. Point-of-care seeding of nitinol stents with blood-derived endothelial cells.Journal of biomedical materials research. Part B, Applied biomaterials · 2016
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Materials (Basel, Switzerland) · 2014
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 2 institutions in 1 country.

Hardean E AchneckDepartment of Surgery, Division of General Surgery, Duke University Medical Center, DUMC Box 2622, Durham, NC 27710, USA. hardean.achneck@duke.edu
Ryan M Jamiolkowski
Alexandra E Jantzen
Justin M Haseltine
Whitney O Lane
Jessica K Huang
Lauren J Galinat
Michael J Serpe
Fu-Hsiung Lin
Madison Li
Amar Parikh
Liqiao Ma
Tao Chen
Bantayehu Sileshi
Carmelo A Milano
Charles S Wallace
Thomas V Stabler
Jason D Allen
George A Truskey
Jeffrey H Lawson
Duke University · USDuke Medical Center · US

Funding

Autologous EPC lining to improve biocompatibility of circulatory assist devicesRC1HL099863 · NHLBI · DUKE UNIVERSITY · PI LAWSON, JEFFREY H. · 2009 to 2010
$990k
Endothelial Progenitor Cell Seeded Self-Expanding Vascular StentR21HL109897 · NHLBI · DUKE UNIVERSITY · PI ACHNECK, HARDEAN ERIC · 2011 to 2012
$432k
NHLBI NIH HHS R21 HL109897NHLBI NIH HHS RC1 HL099863NHLBI NIH HHS RC1HL099863-01
6 · The paper itself

Abstract

Implantable and extracorporeal cardiovascular devices are commonly made from titanium (Ti) (e.g. Ti-coated Nitinol stents and mechanical circulatory assist devices). Endothelializing the blood-contacting Ti surfaces of these devices would provide them with an antithrombogenic coating that mimics the native lining of blood vessels and the heart. We evaluated the viability and adherence of peripheral blood-derived porcine endothelial progenitor cells (EPCs), seeded onto thin Ti layers on glass slides under static conditions and after exposure to fluid shear stresses. EPCs attached and grew to confluence on Ti in serum-free medium, without preadsorption of proteins. After attachment to Ti for 15 min, less than 5% of the cells detached at a shear stress of 100 dyne / cm(2). Confluent monolayers of EPCs on smooth Ti surfaces (Rq of 10 nm), exposed to 15 or 100 dyne/cm(2) for 48 h, aligned and elongated in the direction of flow and produced nitric oxide dependent on the level of shear stress. EPC-coated Ti surfaces had dramatically reduced platelet adhesion when compared to uncoated Ti surfaces. These results indicate that peripheral blood-derived EPCs adhere and function normally on Ti surfaces. Therefore EPCs may be used to seed cardiovascular devices prior to implantation to ameliorate platelet activation and thrombus formation.

Indexed as

Heart-Assist DevicesImplants, ExperimentalAnimalsBiocompatible MaterialsCattleCell AdhesionCell MovementCell ProliferationCell SeparationCell SurvivalEndothelial CellsFibrinolytic AgentsMaterials TestingNitric OxidePlatelet AdhesivenessRheologyBiocompatible MaterialsFibrinolytic AgentsNitric OxideTitanium

Identifiers

PMID20926131
PMCPMC4062098
OpenAlexW1484777774

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.